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• Pluripotent- differentiate into all the cell types 
that make up a body
• The process is very long and not cost-efficient
• Many regulations put in place by the 
government on research conducted using 
embryonically derived stem cells so that 
pregnancy is not purposely terminated to 
provide stem cells
• Most versatile type of stem cells
Mesenchymal Stem Cells
• Adult- derived stem cells
• Can be derived from Adipose Tissue, bone 
marrow, etc.
• Exhibit pluripotent properties
• Useful alternative
• Easy and cost-efficient to derive from an adult 
host
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• Osteoarthritis is the degeneration of articular cartilage and is clinically identified by pain that persists as well as 
stiffness and disability. 
• Patients with osteoarthritis have very few options for effective long-term treatment. 
• Treatments such as pain medications, anti-inflammatories such as nonsteroidal anti-inflammatory drugs (NSAIDs), lubrication, 





• Stem cells derived from bone marrow from the same individual were 
obtained and expanded. 
• A safety test was then conducted on the stem cells that were 
derived from the bone marrow prior to injection. 
• All drugs were stopped 3-4 weeks prior to injection as a control and a 
baseline was measured. Stem cells were then injected into the more 
severely damaged knee.
• The Research Committee and the Ethical Committee of the Tehran 
University of Medical Sciences reviewed this study for the inclusion of 
human subjects and approved it based on the guidelines of the Helsinki 
Declaration
• Results were collected after 6 months and a follow-up study was 




• Six months after the injection of stem cells, range of motion and 
flexion of the knee showed significant improvement across all 
four patients.
• However, five years after the injection the range of motion decreased 
in comparison to six months after the treatment, but still remained 
above the baseline. 
• This is the second experiment ever done on human subjects, the first 
was conducted by Centeno in 2008 and there was an improvement in 
range of motion at 6 months but started to decline again at 12 
months.
• There was also no long term follow up done after a few years to track 
progression. 
• Neither experiment caused any adverse side effects and showed an 
overall improvement in the knee compared to the baseline. 
• However, there are very few test subjects and multiple confounding variables 
that could potentially affect the validity of this data as there are too many 
regulations required to remain within the ethical guidelines.
Jens Martensson
Discussion Questions
• How do you think stem cell research will change/ evolve in the future?
• Will scientists use embryonic stem cells and mesenchymal stem cells in 
the future? Which do you think?
• Do you think mesenchymal stem cells will work as an alternative to 
embryonic stem cells?












More information on embryonic stem cells
• https://stemcells.nih.gov/info/Regenerative_Medicine/2006Chapter1.htm
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